We are live on ! Find out more
QIM

Quantitative Investment Management Portfolio holdings

AUM $917M
1-Year Est. Return 3.96%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
-3.96%
3 Year Est. Return
+24.59%
5 Year Est. Return
+12.41%
10 Year Est. Return
+164.05%
AUM
$3.31B
AUM Growth
+$1.44B
Cap. Flow
+$1.24B
Cap. Flow %
37.52%
Top 10 Hldgs %
18.03%
Holding
852
New
281
Increased
192
Reduced
135
Closed
244

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$68.4M
2
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$61.8M
3
DIS icon
Walt Disney
DIS
+$45.6M
4
META icon
Meta Platforms (Facebook)
META
+$45.1M
5
CRM icon
Salesforce
CRM
+$43.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$43M
2
JPM icon
JPMorgan Chase
JPM
+$42.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$36.3M
4
CELG
Celgene Corp
CELG
+$26.1M
5
BIIB icon
Biogen
BIIB
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 17.35%
2 Miscellaneous 15.33%
3 Healthcare 14.49%
4 Consumer Discretionary 12.68%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACOR
601
DELISTED
Acorda Therapeutics
ACOR
$174K 0.01%
715
+352
+97% +$88.8K
PBI icon
602
Pitney Bowes
PBI
$2.37B
$164K 0.01%
40,771
-22,119
-35% -$101K
HOS
603
Hornbeck Offshore Services, Inc.
HOS
$2.89B
$133K ﹤0.01%
13,910
-3,492
-20% -$30.2K
GPOR
604
DELISTED
Gulfport Energy Corp.
GPOR
$114K ﹤0.01%
37,721
-340,771
-90% -$968K
BCRX icon
605
BioCryst Pharmaceuticals
BCRX
$2.09B
$85K ﹤0.01%
24,704
-4,245
-15% -$10.7K
INO icon
606
Inovio Pharmaceuticals
INO
$120M
$79K ﹤0.01%
+2,013
New +$60.6K
TCRT icon
607
Alaunos Therapeutics
TCRT
$3.58M
$49K ﹤0.01%
70
-1,155
-94% -$795K
YELL
608
DELISTED
Yellow Corporation Common Stock
YELL
$49K ﹤0.01%
19,403
+5,028
+35% +$17.2K
AA icon
609
Alcoa
AA
$12.3B
– –
-14,391
Closed -$288K
AAPL icon
610
Apple
AAPL
$4.84T
– –
-272,376
Closed -$15.3M
ACAD icon
611
Acadia Pharmaceuticals
ACAD
$4.61B
– –
-245,234
Closed -$8.82M
ACM icon
612
Aecom
ACM
$8.26B
– –
-23,381
Closed -$878K
AEIS icon
613
Advanced Energy
AEIS
$10B
– –
-8,880
Closed -$509K
AER icon
614
AerCap
AER
$21.7B
– –
-11,710
Closed -$641K
AIV
615
Aimco
AIV
$333M
– –
-620,678
Closed -$4.31M
ALKS icon
616
Alkermes
ALKS
$7.72B
– –
-22,814
Closed -$445K
ALV icon
617
Autoliv
ALV
$8.51B
– –
-6,091
Closed -$480K
AMGN icon
618
Amgen
AMGN
$203B
– –
-222,042
Closed -$43M
AMKR icon
619
Amkor Technology
AMKR
$11.5B
– –
-11,189
Closed -$101K
AROC icon
620
Archrock
AROC
$5.36B
– –
-14,171
Closed -$141K
ASML icon
621
ASML
ASML
$611B
– –
-1,931
Closed -$479K
AZN icon
622
AstraZeneca
AZN
$251B
– –
-83,837
Closed -$7.47M
BAC icon
623
Bank of America
BAC
$416B
– –
-20,757
Closed -$605K
BC icon
624
Brunswick
BC
$4.46B
– –
-59,879
Closed -$3.12M
BCE icon
625
BCE
BCE
$21.4B
– –
-11,829
Closed -$572K
23 24
25
26 27

Similar funds

HIC
Harvey Investment Company Louisville, Kentucky $918M AUM 14.93% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $917M AUM 87.67% 1-Year Est. Return
RFA
RTD Financial Advisors Philadelphia, Pennsylvania $917M AUM 19.69% 1-Year Est. Return
SPG
Strategic Planning Group Bountiful, Utah $918M AUM 37.38% 1-Year Est. Return
TCM
Twin Capital Management Mcmurray, Pennsylvania $916M AUM 43.28% 1-Year Est. Return
DLP
De Lisle Partners Poole, United Kingdom $916M AUM 54.05% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
GC
Greenvale Capital London, United Kingdom $916M AUM 32.73% 1-Year Est. Return

Quantitative Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Quantitative Investment Management held 852 positions worth $3.31B, up 77% from $1.87B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Quantitative Investment Management deployed $1.24B of net new capital in Q4 2019, opening 281 new positions and adding to 192 existing holdings. Its largest new stake was Meta Platforms (Facebook): 232,923 shares worth $47.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 11% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Lowe's Companies, an estimated $22M trimmed.

  • Quantitative Investment Management's largest Q4 2019 buy was Meta Platforms (Facebook): 232,923 shares worth $47.8M.
  • Quantitative Investment Management added most to iShares MSCI Emerging Markets ETF in Q4 2019, an estimated $68.4M increase.
  • Quantitative Investment Management's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $22M.
  • Quantitative Investment Management fully exited Amgen in Q4 2019, selling an estimated $43M.
  • Quantitative Investment Management's ten largest holdings make up 18% of its $3.31B portfolio in Q4 2019.
  • Quantitative Investment Management opened 281 new positions and closed 244 in Q4 2019.
  • Quantitative Investment Management's portfolio value rose 77% quarter-over-quarter to $3.31B.

Based on Quantitative Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.